KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palvella Therapeutics (PVLA) Preferred Stock Liabilities: 2023

  • Palvella Therapeutics' Preferred Stock Liabilities was N/A to $70.6 million in Q4 2023 from the same period last year, while for Dec 2023 it was $70.6 million, marking a year-over-year change of. This contributed to the annual value of $70.6 million for FY2023, which is N/A change from last year.
  • As of Q4 2023, Palvella Therapeutics' Preferred Stock Liabilities stood at $70.6 million.
  • In the past 5 years, Palvella Therapeutics' Preferred Stock Liabilities ranged from a high of $70.6 million in Q4 2023 and a low of $70.6 million during Q4 2023.
  • In the last 1 years, Palvella Therapeutics' Preferred Stock Liabilities had a median value of $70.6 million in 2023 and averaged $70.6 million.